Cancers, Vol. 13, Pages 5260: Elevated Level of Nerve Growth Factor (NGF) in Serum-Derived Exosomes Predicts Poor Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy
In this study, we examined the roles of cytokines in both serum and exosomes as prognostic biomarkers for long-term outcomes in patients with breast cancer who undergo NAC. We isolated exosomes from the blood of 129 patients with early breast cancer who were receiving neoadjuvant chemotherapy between 2008 and 2011 at Samsung Medical Center. The levels of cytokines and growth factors in serum and exosomes were measured with ProcartaPlex immune-related panels. We investigated correlations between clinic-pathologic variables and patient survival, and Cox proportional hazards regression analysis was performed for prognostic evaluation. We detected significant differences in expression patterns between serum cytokines and exosomal cytokines. In both serum and exosomes, many cytokines were positively correlated with age. In univariate analysis, patients with high serum IP-10, serum MMP-1, and exosomal NGF had shorter overall survival. Exosomal NGF showed significantly poorer overall survival in multivariate analysis. These findings suggest that exosomal NGF is useful for identifying patients with poor survival outcomes.
Source: Cancers - Category: Cancer & Oncology Authors: Hae Hyun Jung Ji-Yeon Kim Eun Yoon Cho Jung Min Oh Jeong Eon Lee Seok Won Kim Seok Jin Nam Yeon Hee Park Jin Seok Ahn Young-Hyuck Im Tags: Article Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Environmental Health | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study